Skip to main content
Premium Trial:

Request an Annual Quote

What Do You Mean, We Have to Ask for Permission?

Ever wonder what would happen if you skipped a step while doing your research? Prominent German anesthesiologist Joachim Boldt is facing just that problem, as he is being investigated for conducting research without first getting permission from the Institutional Review Board , says Pharmalot's Ed Silverman. Several journals are conducting further reviews as they contemplate whether to retract nearly 100 studies, Silverman says. One article, published in December 2009 in Anesthesia & Analgesia, was retracted in October 2010 after no evidence was found of any patient or lab data to suggest that the study was even performed, he adds. Steve Shafer, the editor of Anesthesia & Analgesia, called the situation "unglaublich" — German for "unbelievable" — and says the situation calls for a review of the rules of oversight of investigator-initiated trials, both in Germany and in other countries as well.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.